Glial cell line-derived neurotrophic factor (GDNF), a member of the transforming growth factor (TGF)-β superfamily, has been shown to promote the survival of dopaminergic neurons in midbrain and serve as a promising neuroprotective therapy for PD [1,2,3]. The gene discussed is GDNF; the disease is Parkinson disease.